標(biāo)題: Titlebook: Cytokines in the Treatment of Infectious Diseases; Options for the Modu B.-J. Kullberg,J. W. M. Meer Book 1995 Springer Science+Business Me [打印本頁] 作者: 有靈感 時(shí)間: 2025-3-21 19:53
書目名稱Cytokines in the Treatment of Infectious Diseases影響因子(影響力)
書目名稱Cytokines in the Treatment of Infectious Diseases影響因子(影響力)學(xué)科排名
書目名稱Cytokines in the Treatment of Infectious Diseases網(wǎng)絡(luò)公開度
書目名稱Cytokines in the Treatment of Infectious Diseases網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cytokines in the Treatment of Infectious Diseases被引頻次
書目名稱Cytokines in the Treatment of Infectious Diseases被引頻次學(xué)科排名
書目名稱Cytokines in the Treatment of Infectious Diseases年度引用
書目名稱Cytokines in the Treatment of Infectious Diseases年度引用學(xué)科排名
書目名稱Cytokines in the Treatment of Infectious Diseases讀者反饋
書目名稱Cytokines in the Treatment of Infectious Diseases讀者反饋學(xué)科排名
作者: Pudendal-Nerve 時(shí)間: 2025-3-21 22:01
Cytokines in malaria, pathology and protection,Malaria is among the most important diseases of mankind having a strong negative impact on socioeconomic development. It is a threat to about one third of the world’s population and particularly to people living in tropical and subtropical areas [1–4].作者: 廣大 時(shí)間: 2025-3-22 01:39 作者: MAOIS 時(shí)間: 2025-3-22 05:56 作者: 撫慰 時(shí)間: 2025-3-22 12:25 作者: 拱形大橋 時(shí)間: 2025-3-22 12:52 作者: 拱形大橋 時(shí)間: 2025-3-22 17:38 作者: Electrolysis 時(shí)間: 2025-3-22 22:16 作者: 陪審團(tuán) 時(shí)間: 2025-3-23 01:57 作者: 寒冷 時(shí)間: 2025-3-23 09:24 作者: 敬禮 時(shí)間: 2025-3-23 12:32 作者: hallow 時(shí)間: 2025-3-23 15:13
https://doi.org/10.1007/978-94-009-4289-9 drugs are unable to cure these infections in patients with severely impaired host defense mechanisms. Cytokines have great potential to augment host resistance and as adjunctive therapy of invasive mycoses. We discuss the mechanisms of host defense against invasive candidiasis, aspergillosis, and c作者: 天真 時(shí)間: 2025-3-23 21:02 作者: 相信 時(shí)間: 2025-3-23 22:25 作者: Indurate 時(shí)間: 2025-3-24 05:07
Der Ismus mit menschlichem Antlitzrations in the use of cytokines in this setting, and review the clinical use of a number of cytokines. The best proven example to date is the use of interferon-. in chronic granulomatous disease, which significantly reduces infectious complications of this disease. We also discuss the potential use 作者: 方便 時(shí)間: 2025-3-24 08:18 作者: mortuary 時(shí)間: 2025-3-24 12:24 作者: 輪流 時(shí)間: 2025-3-24 15:21 作者: babble 時(shí)間: 2025-3-24 21:22 作者: BET 時(shí)間: 2025-3-25 03:08 作者: 問到了燒瓶 時(shí)間: 2025-3-25 05:43
Cytokines and legionellosis,effect of interferon gamma on human mononuclear phagocyte iron metabolism and the role of iron availability in . intracellular multiplication in human monocytes has been elucidated. With this knowledge it is now possible to develop treatment strategies for Legionnaires’ disease using interferon gamm作者: 祖先 時(shí)間: 2025-3-25 09:54
The role of cytokines in mycobacterial infection,of protective immunity are poorly known, but cytokines appear to play an important role in the modulation of the immune response. Evidence exists for the role of tumor necrosis factor (TNF-.), granulocyte macrophage colony stimulating factor (GM-CSF) and interferon-gamma (IFN-.) in the host defense 作者: Dislocation 時(shí)間: 2025-3-25 13:32
Cytokines in the treatment of fungal infections, drugs are unable to cure these infections in patients with severely impaired host defense mechanisms. Cytokines have great potential to augment host resistance and as adjunctive therapy of invasive mycoses. We discuss the mechanisms of host defense against invasive candidiasis, aspergillosis, and c作者: 輕快帶來危險(xiǎn) 時(shí)間: 2025-3-25 15:53 作者: 指令 時(shí)間: 2025-3-25 20:24 作者: Aphorism 時(shí)間: 2025-3-26 02:59
Cytokines in the treatment of primary immunodeficiency,rations in the use of cytokines in this setting, and review the clinical use of a number of cytokines. The best proven example to date is the use of interferon-. in chronic granulomatous disease, which significantly reduces infectious complications of this disease. We also discuss the potential use 作者: 披肩 時(shí)間: 2025-3-26 05:52
Cytokines as potential vaccine adjuvants,ection. Candidate populations for such vaccine-adjuvant strategies include normal individuals at the two extremes of life, as well as the ever increasing population of immunocompromised individuals. In addition, adjuvants that would increase the efficiency of vaccination with such vaccines as those 作者: 善辯 時(shí)間: 2025-3-26 09:15
Book 1995from the world‘s key institutes in thisarea. .The book is aimed at microbiologists, immunologists, molecularbiologists, cell biologists and other scientific disciplines in thefield of biotherapy. It is required reading for physicians dealingwith infectious diseases who wish to keep up to date with thedevelopments in this field.作者: 鋼筆記下懲罰 時(shí)間: 2025-3-26 14:29 作者: Eulogy 時(shí)間: 2025-3-26 20:36
Olívia Matos,Ana Magro,António Mexiaeptors and cytokine production, and via induction of acute phase proteins. Moreover, in subacute and chronic infections interleukin-1 interferes with microbial outgrowth, via mechanisms that have only been partially elucidated.作者: 邊緣帶來墨水 時(shí)間: 2025-3-26 23:40
Introduction: Cytokines in the biotherapy of infectious diseases,atients. Only recently a new range of agents has become available that are capable of stimulating and regulating host defense systems. Interleukins, interferons, and hematopoietic growth factors are now being produced by biotechnology industry and are being evaluated for clinical use in this area.作者: 結(jié)合 時(shí)間: 2025-3-27 02:37
Interleukin-1 and related pro-inflammatory cytokines in the treatment of bacterial infections in neeptors and cytokine production, and via induction of acute phase proteins. Moreover, in subacute and chronic infections interleukin-1 interferes with microbial outgrowth, via mechanisms that have only been partially elucidated.作者: tenuous 時(shí)間: 2025-3-27 05:26 作者: 束縛 時(shí)間: 2025-3-27 11:24 作者: Licentious 時(shí)間: 2025-3-27 17:40
Cytokines and legionellosis, monocytes has been elucidated. With this knowledge it is now possible to develop treatment strategies for Legionnaires’ disease using interferon gamma and/or agents affecting human mononuclear phagocyte iron metabolism.作者: Deceit 時(shí)間: 2025-3-27 18:54 作者: 珊瑚 時(shí)間: 2025-3-27 23:31
Der Ismus mit menschlichem Antlitzof interferon-. in the hyperimmunoglobulin E syndrome and in newborns. Granulocyte-colony stimulating factor usage in congenital neutropenias is reviewed. The use of IL-2, thymic hormones, and interferon-. are briefly discussed. Strategies for the design of clinical trials of cytokines in these uncommon illnesses are proposed.作者: CHASM 時(shí)間: 2025-3-28 02:23
Cytokines in the treatment of primary immunodeficiency,of interferon-. in the hyperimmunoglobulin E syndrome and in newborns. Granulocyte-colony stimulating factor usage in congenital neutropenias is reviewed. The use of IL-2, thymic hormones, and interferon-. are briefly discussed. Strategies for the design of clinical trials of cytokines in these uncommon illnesses are proposed.作者: Abominate 時(shí)間: 2025-3-28 09:38
nisms. Interleukins, interferons and haematopoietic growthfactors are now being produced by the biotechnology industry and arebeing evaluated for clinical use in this area. ..Cytokines in the Treatment of Infectious Diseases. provides aunique, up-to-date survey of this research area. The use of cyto作者: 鈍劍 時(shí)間: 2025-3-28 10:30
Moutoshi Chakraborty,Tofazzal Islamht in the role of various cytokines in the host defense against these pathogens is required. The present contribution summarizes the results of various studies on the role of different cytokines in the host defense against the intracellular bacteria . and ..作者: 混沌 時(shí)間: 2025-3-28 15:35
Ali Talha Khalil,Zabta Khan Shinwari monocytes has been elucidated. With this knowledge it is now possible to develop treatment strategies for Legionnaires’ disease using interferon gamma and/or agents affecting human mononuclear phagocyte iron metabolism.作者: Graduated 時(shí)間: 2025-3-28 21:08
R.Z Sayyed,Anjana Singh,Noshiin Ilyasthe role of tumor necrosis factor (TNF-.), granulocyte macrophage colony stimulating factor (GM-CSF) and interferon-gamma (IFN-.) in the host defense against mycobacteria. In this article we discuss recent findings about the role of cytokines in leprosy, tuberculosis and . infection, using . and . human and murine data.作者: 肉身 時(shí)間: 2025-3-29 02:54 作者: cortex 時(shí)間: 2025-3-29 06:29
Cytokines in the treatment of fungal infections,ain mechanism by which interferon- . enhances the elimination of .,and consequently the agent is not effective in severly granulocytopenic animals. Data on the role of colony-stimulating factors against fungal pathogens are accumulating, and trials with these agents for hematologic patients with inv作者: flammable 時(shí)間: 2025-3-29 09:09
Cytokines in the treatment of leishmaniasis: From studies of immunopathology to patient therapy,atients lend support to this concept of altered immunomodulation. Furthermore, the enhancement of therapeutic response by interferon-. has provided a new approach for treatment of patients using recombinant cytokines and for the study of the disease. Current research for early diagnosis, alternative作者: Panther 時(shí)間: 2025-3-29 12:37 作者: ascetic 時(shí)間: 2025-3-29 18:12 作者: 事與愿違 時(shí)間: 2025-3-29 19:45
other scientific disciplines in thefield of biotherapy. It is required reading for physicians dealingwith infectious diseases who wish to keep up to date with thedevelopments in this field.978-94-010-4104-1978-94-011-0233-9作者: 文藝 時(shí)間: 2025-3-30 01:28
Mehdi Razzaghi-Abyaneh,Mahendra Raichronic papillomavirus infections. The doses routinely used are associated with both acute and chronic toxic side effects. Also, some patients form specific neutralising antibodies against the particular IFN preparation injected, which may abrogate all the benefits of the treatment. Nevertheless, IF作者: Mercantile 時(shí)間: 2025-3-30 06:11
